Hyperforin inhibits cell proliferation and differentiation in mouse embryonic stem cells

Cell Proliferation

Volumn 46, Issue 5, 2013, Pages 529-537

  Nakamura, K ^a   Aizawa, K ^a   Yamauchi, J ^a   Tanoue, A ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CASPASE 3; CASPASE 8; CASPASE 9; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPERFORIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CYTOTOXICITY TEST; DEVELOPMENTAL TOXICITY; EMBRYO; EMBRYONIC STEM CELL; EMBRYOTOXICITY; FIBROBLAST; GENE EXPRESSION; HEART MUSCLE CELL; MOUSE; NONHUMAN;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; HYPERICUM; MICE; NIH 3T3 CELLS; PHLOROGLUCINOL; PSYCHOTROPIC DRUGS; TERPENES;

EID: 84884704594     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12060     Document Type: Article

References (25)

1. Calixto JB, Campos MM, Otuki MF, Santos AR (2004) Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med. 70, 93-103.
2. Calixto JB, Otuki MF, Santos AR (2003) Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B (NF-kappaB). Planta Med. 69, 973-983.
3. Bailly C (2009) Ready for a comeback of natural products in oncology. Biochem. Pharmacol. 77, 1447-1457.
4. Medina MA, Martinez-Poveda B, Amores-Sanchez MI, Quesada AR (2006) Hyperforin: more than an antidepressant bioactive compound? Life Sci. 79, 105-111.
5. Quiney C, Billard C, Salanoubat C, Fourneron JD, Kolb JP (2006) Hyperforin, a new lead compound against the progression of cancer and leukemia? Leukemia 20, 1519-1525.
6. Borrelli F, Izzo AA (2009) Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. AAPS J. 11, 710-727.
7. Hostanska K, Reichling J, Bommer S, Weber M, Saller R (2003) Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines. Eur. J. Pharm. Biopharm. 56, 121-132.
8. Liu JY, Liu Z, Wang DM, Li MM, Wang SX, Wang R et al. (2011) Induction of apoptosis in K562 cells by dicyclohexylammonium salt of hyperforin through a mitochondrial-related pathway. Chem. Biol. Interact. 190, 91-101.
9. Genschow E, Spielmann H, Scholz G, Pohl I, Seiler A, Clemann N et al. (2004) Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern. Lab. Anim. 32, 209-244.
10. Spielmann H, Pohl I, Droing B, Liebsch M, Moldenhauser F (1997) The embryonic stem cell test, in vitro embryo toxicity test using two permanent mouse cell line: 3T3 fibroblast and embryonic stem cells. In Vitro Toxicol. 10, 119-127.
11. Seiler AE, Spielmann H (2011) The validated embryonic stem cell test to predict embryotoxicity in vitro. Nat. Protoc. 6, 961-978.
12. Murabe M, Yamauchi J, Fujiwara Y, Hiroyama M, Sanbe A, Tanoue A (2007) A novel embryotoxic estimation method of VPA using ES cells differentiation system. Biochem. Biophys. Res. Commun. 352, 164-169.
13. Murabe M, Yamauchi J, Fujiwara Y, Miyamoto Y, Hiroyama M, Sanbe A et al. (2007) Estimation of the embryotoxic effect of CBZ using an ES cell differentiation system. Biochem. Biophys. Res. Commun. 356, 739-744.
14. Kusakawa S, Yamauchi J, Miyamoto Y, Sanbe A, Tanoue A (2008) Estimation of embryotoxic effect of fluoxetine using embryonic stem cell differentiation system. Life Sci. 83, 871-877.
15. Wang ZB, Liu YQ, Cui YF (2005) Pathways to caspase activation. Cell Biol. Int. 29, 489-496.
16. Miura T, Mattson MP, Rao MS (2004) Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell 3, 333-343.
17. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B et al. (2012) Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 45, 487-498.
18. Suzanne M, Steller H (2013) Shaping organisms with apoptosis. Cell Death Differ. 20, 669-675.
19. Green DR, Galluzzi L, Kroemer G (2011) Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 333, 1109-1112.
20. Wlodkowic D, Skommer J, Darzynkiewicz Z (2010) Cytometry in cell necrobiology revisited. Recent advances and new vistas. Cytometry A 77, 591-606.
21. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A (1994) Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J. Immunol. 153, 1778-1788.
22. Liedtke C, Plumpe J, Kubicka S, Bradham CA, Manns MP, Brenner DA et al. (2002) Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells. Hepatology 36, 315-325.
23. Agrosi M, Mischiatti S, Harrasser PC, Savio D (2000) Oral bioavailability of active principles from herbal products in humans. A study on Hypericum perforatum extracts using the soft gelatin capsule technology. Phytomedicine 7, 455-462.
24. Vitiello B, Shader RI, Parker CB, Ritz L, Harlan W, Greenblatt DJ et al. (2005) Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial. J. Clin. Psychopharmacol. 25, 243-249.
25. Moretti ME, Maxson A, Hanna F, Koren G (2009) Evaluating the safety of St. John's Wort in human pregnancy. Reprod. Toxicol. 28, 96-99.